ArticleJournal of multidisciplinary healthcare2025
Research Trends and Hotspots in JAK Inhibitors for Ulcerative Colitis: A Bibliometric Analysis From 2015 to 2024.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Research hotspots, context, and future directions of ulcerative colitis comorbid with depression from 2006 to 2025: a bibliometric and visualization analysis.Frontiers in medicine · 2026Pooled it
- Research on adaptive collaborative dispatch optimization algorithms for drones in distribution networks.Scientific reports · 2026Article
- Network Pharmacology-Metabolomics Integration Reveals the Multiple Targets and Mechanisms of Total Glucosides of Paeony Against Ulcerative Colitis.Journal of inflammation research · 2026Article
- Global trends and hotspots of artificial intelligence in pain management: A bibliometric analysis.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically investigate international trends and dynamics in research on Janus kinase (JAK) inhibitor applications for ulcerative colitis (UC) management over the past decade (2015-2024) and delineate current research frontiers. Methods: Publications was retrieved from the Web of Science core collection database and subjected to bibliometric analysis. VOSviewers, CiteSpace, Scimago Graphica, and Excel were used to conduct this bibliometric analysis and visualization. Results: A total of 696 articles were included. Publication output exhibited an overall upward trajectory. The United States ranked first in global publication volume and served as the central hub for multiple extensive collaborative networks. Conclusion: This study delineates the evolution of JAK inhibitor research in UC over the past decade. Future efforts should prioritize strengthening global collaboration, advancing novel subtype selective JAK inhibitors, generating long-term safety data from clinical trials, and optimizing patient-stratified treatment strategies to address unmet therapeutic needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.